NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals
Estimated value
—
Awarded value
—
Suppliers
63
Lots
2
Published
06 Apr 2023
Description
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals<br/><br/>Offer reference number: CM/PHR/22/5675<br/><br/>CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Scope
- Reference
- CM/PHR/22/5675
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2023 to 30 Apr 2025
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 63 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – Lot 1 | £613.9m | cancelled |
| 2 | CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – Lot 2 | £105.7m | cancelled |